nodes	percent_of_prediction	percent_of_DWPC	metapath
Goserelin—Reaction aggravation—Riluzole—amyotrophic lateral sclerosis	0.0732	0.0778	CcSEcCtD
Goserelin—Adverse reaction—Riluzole—amyotrophic lateral sclerosis	0.0732	0.0778	CcSEcCtD
Goserelin—Condition aggravated—Riluzole—amyotrophic lateral sclerosis	0.042	0.0447	CcSEcCtD
Goserelin—Proctitis—Riluzole—amyotrophic lateral sclerosis	0.0315	0.0334	CcSEcCtD
Goserelin—Uterine leiomyoma—Riluzole—amyotrophic lateral sclerosis	0.0294	0.0313	CcSEcCtD
Goserelin—Uterine haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.022	0.0233	CcSEcCtD
Goserelin—GNRHR—hindbrain—amyotrophic lateral sclerosis	0.0219	0.374	CbGeAlD
Goserelin—Cerebral ischaemia—Riluzole—amyotrophic lateral sclerosis	0.0159	0.0169	CcSEcCtD
Goserelin—Peripheral vascular disorder—Riluzole—amyotrophic lateral sclerosis	0.0157	0.0166	CcSEcCtD
Goserelin—Osteoporosis—Riluzole—amyotrophic lateral sclerosis	0.0137	0.0146	CcSEcCtD
Goserelin—Polyp—Riluzole—amyotrophic lateral sclerosis	0.0126	0.0134	CcSEcCtD
Goserelin—Libido increased—Riluzole—amyotrophic lateral sclerosis	0.0126	0.0134	CcSEcCtD
Goserelin—GNRHR—brainstem—amyotrophic lateral sclerosis	0.0126	0.214	CbGeAlD
Goserelin—Cyst—Riluzole—amyotrophic lateral sclerosis	0.0115	0.0122	CcSEcCtD
Goserelin—Seborrhoeic dermatitis—Riluzole—amyotrophic lateral sclerosis	0.0113	0.012	CcSEcCtD
Goserelin—Hypercalcaemia—Riluzole—amyotrophic lateral sclerosis	0.0111	0.0117	CcSEcCtD
Goserelin—Haematemesis—Riluzole—amyotrophic lateral sclerosis	0.0111	0.0117	CcSEcCtD
Goserelin—Metrorrhagia—Riluzole—amyotrophic lateral sclerosis	0.0108	0.0114	CcSEcCtD
Goserelin—Amblyopia—Riluzole—amyotrophic lateral sclerosis	0.00994	0.0106	CcSEcCtD
Goserelin—Endocrine disorder—Riluzole—amyotrophic lateral sclerosis	0.00926	0.00984	CcSEcCtD
Goserelin—Breast pain—Riluzole—amyotrophic lateral sclerosis	0.0088	0.00935	CcSEcCtD
Goserelin—Amenorrhoea—Riluzole—amyotrophic lateral sclerosis	0.00874	0.00928	CcSEcCtD
Goserelin—Bone disorder—Riluzole—amyotrophic lateral sclerosis	0.0085	0.00903	CcSEcCtD
Goserelin—Arthropathy—Riluzole—amyotrophic lateral sclerosis	0.00844	0.00897	CcSEcCtD
Goserelin—Thinking abnormal—Riluzole—amyotrophic lateral sclerosis	0.00839	0.00891	CcSEcCtD
Goserelin—Cough increased—Riluzole—amyotrophic lateral sclerosis	0.00839	0.00891	CcSEcCtD
Goserelin—Nocturia—Riluzole—amyotrophic lateral sclerosis	0.00828	0.00879	CcSEcCtD
Goserelin—Gout—Riluzole—amyotrophic lateral sclerosis	0.00822	0.00874	CcSEcCtD
Goserelin—Hypercholesterolaemia—Riluzole—amyotrophic lateral sclerosis	0.00812	0.00862	CcSEcCtD
Goserelin—Ulcer—Riluzole—amyotrophic lateral sclerosis	0.00812	0.00862	CcSEcCtD
Goserelin—Pulmonary embolism—Riluzole—amyotrophic lateral sclerosis	0.00768	0.00816	CcSEcCtD
Goserelin—Injection site reaction—Riluzole—amyotrophic lateral sclerosis	0.00763	0.00811	CcSEcCtD
Goserelin—Urinary incontinence—Riluzole—amyotrophic lateral sclerosis	0.00741	0.00788	CcSEcCtD
Goserelin—Cramps of lower extremities—Riluzole—amyotrophic lateral sclerosis	0.00705	0.00749	CcSEcCtD
Goserelin—Ecchymosis—Riluzole—amyotrophic lateral sclerosis	0.00694	0.00738	CcSEcCtD
Goserelin—Neoplasm—Riluzole—amyotrophic lateral sclerosis	0.00694	0.00738	CcSEcCtD
Goserelin—Hypertonia—Riluzole—amyotrophic lateral sclerosis	0.00673	0.00715	CcSEcCtD
Goserelin—Mental disability—Riluzole—amyotrophic lateral sclerosis	0.00666	0.00708	CcSEcCtD
Goserelin—Sepsis—Riluzole—amyotrophic lateral sclerosis	0.00666	0.00708	CcSEcCtD
Goserelin—GNRHR—nervous system—amyotrophic lateral sclerosis	0.00658	0.112	CbGeAlD
Goserelin—Diabetes mellitus—Riluzole—amyotrophic lateral sclerosis	0.00641	0.00681	CcSEcCtD
Goserelin—Hepatic function abnormal—Riluzole—amyotrophic lateral sclerosis	0.00638	0.00678	CcSEcCtD
Goserelin—GNRHR—central nervous system—amyotrophic lateral sclerosis	0.00634	0.108	CbGeAlD
Goserelin—GNRHR—cerebellum—amyotrophic lateral sclerosis	0.0062	0.106	CbGeAlD
Goserelin—Cardiac failure congestive—Riluzole—amyotrophic lateral sclerosis	0.00615	0.00653	CcSEcCtD
Goserelin—Libido decreased—Riluzole—amyotrophic lateral sclerosis	0.00601	0.00639	CcSEcCtD
Goserelin—Amnesia—Riluzole—amyotrophic lateral sclerosis	0.00593	0.0063	CcSEcCtD
Goserelin—Increased appetite—Riluzole—amyotrophic lateral sclerosis	0.00593	0.0063	CcSEcCtD
Goserelin—Thirst—Riluzole—amyotrophic lateral sclerosis	0.00586	0.00622	CcSEcCtD
Goserelin—Cardiac failure—Riluzole—amyotrophic lateral sclerosis	0.00571	0.00607	CcSEcCtD
Goserelin—Osteoarthritis—Riluzole—amyotrophic lateral sclerosis	0.00557	0.00592	CcSEcCtD
Goserelin—Disturbance in sexual arousal—Riluzole—amyotrophic lateral sclerosis	0.00553	0.00587	CcSEcCtD
Goserelin—Migraine—Riluzole—amyotrophic lateral sclerosis	0.00549	0.00583	CcSEcCtD
Goserelin—Affect lability—Riluzole—amyotrophic lateral sclerosis	0.00549	0.00583	CcSEcCtD
Goserelin—Psychotic disorder—Riluzole—amyotrophic lateral sclerosis	0.00544	0.00578	CcSEcCtD
Goserelin—Urinary retention—Riluzole—amyotrophic lateral sclerosis	0.0053	0.00563	CcSEcCtD
Goserelin—Mood swings—Riluzole—amyotrophic lateral sclerosis	0.00528	0.00561	CcSEcCtD
Goserelin—Breast disorder—Riluzole—amyotrophic lateral sclerosis	0.00504	0.00535	CcSEcCtD
Goserelin—GNRHR—brain—amyotrophic lateral sclerosis	0.00503	0.0858	CbGeAlD
Goserelin—Influenza—Riluzole—amyotrophic lateral sclerosis	0.00482	0.00512	CcSEcCtD
Goserelin—Angina pectoris—Riluzole—amyotrophic lateral sclerosis	0.00469	0.00499	CcSEcCtD
Goserelin—Bronchitis—Riluzole—amyotrophic lateral sclerosis	0.00463	0.00492	CcSEcCtD
Goserelin—Dysuria—Riluzole—amyotrophic lateral sclerosis	0.00451	0.00479	CcSEcCtD
Goserelin—Pollakiuria—Riluzole—amyotrophic lateral sclerosis	0.00445	0.00473	CcSEcCtD
Goserelin—Erectile dysfunction—Riluzole—amyotrophic lateral sclerosis	0.00444	0.00471	CcSEcCtD
Goserelin—Photosensitivity reaction—Riluzole—amyotrophic lateral sclerosis	0.0044	0.00467	CcSEcCtD
Goserelin—Weight increased—Riluzole—amyotrophic lateral sclerosis	0.00438	0.00466	CcSEcCtD
Goserelin—Pneumonia—Riluzole—amyotrophic lateral sclerosis	0.00432	0.00459	CcSEcCtD
Goserelin—Depression—Riluzole—amyotrophic lateral sclerosis	0.00428	0.00455	CcSEcCtD
Goserelin—Acute coronary syndrome—Riluzole—amyotrophic lateral sclerosis	0.00423	0.0045	CcSEcCtD
Goserelin—Myocardial infarction—Riluzole—amyotrophic lateral sclerosis	0.00421	0.00447	CcSEcCtD
Goserelin—Jaundice—Riluzole—amyotrophic lateral sclerosis	0.00419	0.00445	CcSEcCtD
Goserelin—Urinary tract infection—Riluzole—amyotrophic lateral sclerosis	0.00418	0.00444	CcSEcCtD
Goserelin—Sweating—Riluzole—amyotrophic lateral sclerosis	0.00412	0.00437	CcSEcCtD
Goserelin—Haematuria—Riluzole—amyotrophic lateral sclerosis	0.0041	0.00435	CcSEcCtD
Goserelin—Epistaxis—Riluzole—amyotrophic lateral sclerosis	0.00405	0.0043	CcSEcCtD
Goserelin—Sinusitis—Riluzole—amyotrophic lateral sclerosis	0.00403	0.00428	CcSEcCtD
Goserelin—Haemoglobin—Riluzole—amyotrophic lateral sclerosis	0.00388	0.00412	CcSEcCtD
Goserelin—Rhinitis—Riluzole—amyotrophic lateral sclerosis	0.00387	0.00411	CcSEcCtD
Goserelin—Haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.00386	0.0041	CcSEcCtD
Goserelin—Hepatitis—Riluzole—amyotrophic lateral sclerosis	0.00386	0.0041	CcSEcCtD
Goserelin—Pharyngitis—Riluzole—amyotrophic lateral sclerosis	0.00383	0.00407	CcSEcCtD
Goserelin—Urinary tract disorder—Riluzole—amyotrophic lateral sclerosis	0.00381	0.00405	CcSEcCtD
Goserelin—Oedema peripheral—Riluzole—amyotrophic lateral sclerosis	0.0038	0.00404	CcSEcCtD
Goserelin—Urethral disorder—Riluzole—amyotrophic lateral sclerosis	0.00378	0.00402	CcSEcCtD
Goserelin—Eye disorder—Riluzole—amyotrophic lateral sclerosis	0.0036	0.00383	CcSEcCtD
Goserelin—Cardiac disorder—Riluzole—amyotrophic lateral sclerosis	0.00358	0.0038	CcSEcCtD
Goserelin—Angiopathy—Riluzole—amyotrophic lateral sclerosis	0.0035	0.00372	CcSEcCtD
Goserelin—Immune system disorder—Riluzole—amyotrophic lateral sclerosis	0.00348	0.0037	CcSEcCtD
Goserelin—Chills—Riluzole—amyotrophic lateral sclerosis	0.00346	0.00368	CcSEcCtD
Goserelin—Arrhythmia—Riluzole—amyotrophic lateral sclerosis	0.00344	0.00366	CcSEcCtD
Goserelin—Alopecia—Riluzole—amyotrophic lateral sclerosis	0.00341	0.00362	CcSEcCtD
Goserelin—Mental disorder—Riluzole—amyotrophic lateral sclerosis	0.00338	0.00359	CcSEcCtD
Goserelin—Malnutrition—Riluzole—amyotrophic lateral sclerosis	0.00336	0.00357	CcSEcCtD
Goserelin—Flatulence—Riluzole—amyotrophic lateral sclerosis	0.00331	0.00351	CcSEcCtD
Goserelin—Tension—Riluzole—amyotrophic lateral sclerosis	0.00329	0.0035	CcSEcCtD
Goserelin—Nervousness—Riluzole—amyotrophic lateral sclerosis	0.00326	0.00346	CcSEcCtD
Goserelin—Back pain—Riluzole—amyotrophic lateral sclerosis	0.00325	0.00345	CcSEcCtD
Goserelin—Muscle spasms—Riluzole—amyotrophic lateral sclerosis	0.00323	0.00343	CcSEcCtD
Goserelin—Ill-defined disorder—Riluzole—amyotrophic lateral sclerosis	0.00311	0.00331	CcSEcCtD
Goserelin—Anaemia—Riluzole—amyotrophic lateral sclerosis	0.0031	0.0033	CcSEcCtD
Goserelin—Malaise—Riluzole—amyotrophic lateral sclerosis	0.00303	0.00322	CcSEcCtD
Goserelin—Leukopenia—Riluzole—amyotrophic lateral sclerosis	0.003	0.00319	CcSEcCtD
Goserelin—Palpitations—Riluzole—amyotrophic lateral sclerosis	0.00297	0.00315	CcSEcCtD
Goserelin—Cough—Riluzole—amyotrophic lateral sclerosis	0.00293	0.00311	CcSEcCtD
Goserelin—Convulsion—Riluzole—amyotrophic lateral sclerosis	0.00291	0.00309	CcSEcCtD
Goserelin—Hypertension—Riluzole—amyotrophic lateral sclerosis	0.0029	0.00308	CcSEcCtD
Goserelin—Chest pain—Riluzole—amyotrophic lateral sclerosis	0.00286	0.00304	CcSEcCtD
Goserelin—Myalgia—Riluzole—amyotrophic lateral sclerosis	0.00286	0.00304	CcSEcCtD
Goserelin—Arthralgia—Riluzole—amyotrophic lateral sclerosis	0.00286	0.00304	CcSEcCtD
Goserelin—Anxiety—Riluzole—amyotrophic lateral sclerosis	0.00285	0.00303	CcSEcCtD
Goserelin—Unspecified disorder of skin and subcutaneous tissue—Riluzole—amyotrophic lateral sclerosis	0.00284	0.00302	CcSEcCtD
Goserelin—Discomfort—Riluzole—amyotrophic lateral sclerosis	0.00282	0.003	CcSEcCtD
Goserelin—Dry mouth—Riluzole—amyotrophic lateral sclerosis	0.0028	0.00297	CcSEcCtD
Goserelin—Confusional state—Riluzole—amyotrophic lateral sclerosis	0.00276	0.00293	CcSEcCtD
Goserelin—Oedema—Riluzole—amyotrophic lateral sclerosis	0.00274	0.00291	CcSEcCtD
Goserelin—Anaphylactic shock—Riluzole—amyotrophic lateral sclerosis	0.00274	0.00291	CcSEcCtD
Goserelin—Infection—Riluzole—amyotrophic lateral sclerosis	0.00272	0.00289	CcSEcCtD
Goserelin—Shock—Riluzole—amyotrophic lateral sclerosis	0.0027	0.00286	CcSEcCtD
Goserelin—Nervous system disorder—Riluzole—amyotrophic lateral sclerosis	0.00269	0.00285	CcSEcCtD
Goserelin—Thrombocytopenia—Riluzole—amyotrophic lateral sclerosis	0.00268	0.00285	CcSEcCtD
Goserelin—Tachycardia—Riluzole—amyotrophic lateral sclerosis	0.00267	0.00284	CcSEcCtD
Goserelin—Skin disorder—Riluzole—amyotrophic lateral sclerosis	0.00266	0.00283	CcSEcCtD
Goserelin—Hyperhidrosis—Riluzole—amyotrophic lateral sclerosis	0.00265	0.00281	CcSEcCtD
Goserelin—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.00261	0.00277	CcSEcCtD
Goserelin—Hypotension—Riluzole—amyotrophic lateral sclerosis	0.00256	0.00272	CcSEcCtD
Goserelin—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.0025	0.00265	CcSEcCtD
Goserelin—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.00248	0.00263	CcSEcCtD
Goserelin—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.00246	0.00261	CcSEcCtD
Goserelin—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.00244	0.00259	CcSEcCtD
Goserelin—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.00244	0.00259	CcSEcCtD
Goserelin—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.00241	0.00256	CcSEcCtD
Goserelin—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.00238	0.00253	CcSEcCtD
Goserelin—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.00236	0.00251	CcSEcCtD
Goserelin—Constipation—Riluzole—amyotrophic lateral sclerosis	0.00234	0.00249	CcSEcCtD
Goserelin—Pain—Riluzole—amyotrophic lateral sclerosis	0.00234	0.00249	CcSEcCtD
Goserelin—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.00226	0.0024	CcSEcCtD
Goserelin—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.00224	0.00238	CcSEcCtD
Goserelin—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.00218	0.00231	CcSEcCtD
Goserelin—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.00217	0.0023	CcSEcCtD
Goserelin—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.00217	0.0023	CcSEcCtD
Goserelin—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.00202	0.00214	CcSEcCtD
Goserelin—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.00197	0.00209	CcSEcCtD
Goserelin—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.00194	0.00206	CcSEcCtD
Goserelin—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.00187	0.00199	CcSEcCtD
Goserelin—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.00181	0.00192	CcSEcCtD
Goserelin—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.00174	0.00185	CcSEcCtD
Goserelin—Rash—Riluzole—amyotrophic lateral sclerosis	0.00173	0.00184	CcSEcCtD
Goserelin—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.00173	0.00183	CcSEcCtD
Goserelin—Headache—Riluzole—amyotrophic lateral sclerosis	0.00172	0.00182	CcSEcCtD
Goserelin—Nausea—Riluzole—amyotrophic lateral sclerosis	0.00163	0.00173	CcSEcCtD
